Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
147
days
Inflammatory Signaling and Emotional Symptoms in Hashimoto’s Thyroiditis beyond Thyroid Function Status
Authors
Simiao Yao; Xingyu Zhu; Xin’ai Li; Xinying Si; Qian Zhang; Zhiguo Ding; Junhui WangShow moreShow less
Affiliations
1. Department of Thyropathy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China; 2. Shaanxi Province Key Laboratory of Integrated Traditional Chinese and Western Medicine for the Prevention and Treatment of Thyroid Diseases, Sun Si Miao Hospital, Beijing University of Chinese Medicine, Tongchuan, China; 3. Traditional Chinese Medicine School, Hainan Medical University, Haikou, China; 4. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, CanadaShow moreShow less
56
days
Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001)
Authors
Hiroyuki Okuyama; Taro Shibuki; Naohiro Okano; Takuro Mizukami; Hiroaki Yanagimoto; Mao Okada; Emiri Kita; Noritoshi Kobayashi; Satoshi Kobayashi; Takaaki Furukawa; Hiroyuki Asama; Hidetaka Tsumura; Ken Kamata; Kumiko Umemoto; Yasuo Hamamoto; Yuko Suzuki; Shigeru Horiguchi; Atsushi Naganuma; Akinori Asagi; Kunihiro Tsuji; Ryoji Takada; Kazuhito Kawata; Motohiro Kojima; Hiroshi Imaoka; Takeshi Terashima; Masato Ozaka; Makoto Ueno; Masafumi IkedaShow moreShow less
Affiliations
1. Department of Medical Oncology, Kagawa University Hospital, Miki, Japan; 2. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; 3. Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan; 4. Department of Medical Oncology, NTT Medical Center Tokyo, Tokyo, Japan; 5. Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan; 6. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan; 7. Department of Gastroenterology, Chiba Cancer Center, Chiba, Japan; 8. Department of Oncology, Yokohama City University School of Medicine, Yokohama, Japan; 9. Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan; 10. Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; 11. Department of Gastroenterology, School of Medicine, Fukushima Medical University, Fukushima, Japan; 12. Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan; 13. Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan; 14. Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan; 15. Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan; 16. Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan; 17. Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan; 18. Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan; 19. Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan; 20. Department of Medical Oncology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan; 21. Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan; 22. Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Japan; 23. Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; 24. Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, JapanShow moreShow less
172
days
Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine Tumors
Authors
Na Zhou; Guofeng Zhao; Yang Gao; Jiazhang Xing; Mingying Wu; Hongyan Ying; Mei Guan; Huanwen Wu; Lin Zhao; Chunmei Bai; Yuejuan ChengShow moreShow less
Affiliations
1. Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2. Department of Medicine, University of California San Diego, San Diego, CA, USA; 3. Department of Medical Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; 4. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaShow moreShow less
134
days
Real-World Patient Outcomes on the Efficacy of Lanreotide Treatment for Neuroendocrine Tumors: The Influence of Body Mass Index, Body Surface Area, and Renal Function
Authors
Ilse de Weert; Mirjam Crul; Heinz-Josef Klümpen; Tim SchutteShow moreShow less
Affiliations
1. Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands; 2. Department of Medical Oncology, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands; 3. Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsShow moreShow less
175
days
Unveiling the Prognostic Role of Synaptophysin in Conventional Colorectal Carcinomas
Authors
Giovanna Sabella; Giovanni Centonze; Vincenzo Lagano; Andrea Scardino; Filiberto Belli; Giovanna Garzone; Carlotta Pardo; Daniela Galbiati; Sara Pusceddu; Alessandro Mangogna; Valentina Angerilli; Matteo Fassan; Andrea Vingiani; Luca Agnelli; Giancarlo Pruneri; Stefania Gobba; Silvia Uccella; Stefano La Rosa; Fausto Sessa; Carlo Capella; Massimo MilioneShow moreShow less
Affiliations
1. 1st Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 2. Colorectal Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 3. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 4. Department of Medicine (DMED), Institute of Pathological Anatomy, University of Udine, Udine, Italy; 5. Department of Life Sciences, University of Trieste, Trieste, Italy; 6. Department of Medicine (DIMED), University of Padua, Padua, Italy; 7. Veneto Institute of Oncology IOV, IRCCS, Padua, Italy; 8. Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 9. Department of Oncology, ASST Sette Laghi, Varese, Italy; 10. Department of Biomedical Sciences, Humanitas University, Milan, Italy; 11. Pathology Service, IRCSS Humanitas Research Hospital, Milan, Italy; 12. Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy; 13. Unit of Pathology, Department of Oncology, ASST Sette Laghi, Varese, ItalyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days